Literature DB >> 19956378

Quantitative imaging for evaluation of response to cancer therapy.

Laurence P Clarke1, Barbara S Croft, Robert Nordstrom, Huiming Zhang, Gary Kelloff, J Tatum.   

Abstract

Entities:  

Year:  2009        PMID: 19956378      PMCID: PMC2781068          DOI: 10.1593/tlo.09217

Source DB:  PubMed          Journal:  Transl Oncol        ISSN: 1936-5233            Impact factor:   4.243


× No keyword cloud information.
  16 in total

1.  Imaging as a tumor biomarker in oncology drug trials for lung cancer: the FDA perspective.

Authors:  N Petrick; D G Brown; O Suleiman; K J Myers
Journal:  Clin Pharmacol Ther       Date:  2008-10       Impact factor: 6.875

2.  Imaging as a biomarker for therapy response: cancer as a prototype for the creation of research resources.

Authors:  G McLennan; L Clarke; R J Hohl
Journal:  Clin Pharmacol Ther       Date:  2008-10       Impact factor: 6.875

Review 3.  The progress and promise of molecular imaging probes in oncologic drug development.

Authors:  Gary J Kelloff; Kenneth A Krohn; Steven M Larson; Ralph Weissleder; David A Mankoff; John M Hoffman; Jeanne M Link; Kathryn Z Guyton; William C Eckelman; Howard I Scher; Joyce O'Shaughnessy; Bruce D Cheson; Caroline C Sigman; James L Tatum; George Q Mills; Daniel C Sullivan; Janet Woodcock
Journal:  Clin Cancer Res       Date:  2005-11-15       Impact factor: 12.531

Review 4.  Progress and promise of FDG-PET imaging for cancer patient management and oncologic drug development.

Authors:  Gary J Kelloff; John M Hoffman; Bruce Johnson; Howard I Scher; Barry A Siegel; Edward Y Cheng; Bruce D Cheson; Joyce O'shaughnessy; Kathryn Z Guyton; David A Mankoff; Lalitha Shankar; Steven M Larson; Caroline C Sigman; Richard L Schilsky; Daniel C Sullivan
Journal:  Clin Cancer Res       Date:  2005-04-15       Impact factor: 12.531

5.  PET/CT Assessment of Response to Therapy: Tumor Change Measurement, Truth Data, and Error.

Authors:  Paul E Kinahan; Robert K Doot; Michelle Wanner-Roybal; Luc M Bidaut; Samuel G Armato; Charles R Meyer; Geoffrey McLennan
Journal:  Transl Oncol       Date:  2009-12       Impact factor: 4.243

6.  Computed tomography assessment of response to therapy: tumor volume change measurement, truth data, and error.

Authors:  Michael F McNitt-Gray; Luc M Bidaut; Samuel G Armato; Charles R Meyer; Marios A Gavrielides; Charles Fenimore; Geoffrey McLennan; Nicholas Petrick; Binsheng Zhao; Anthony P Reeves; Reinhard Beichel; Hyun-Jung Grace Kim; Lisa Kinnard
Journal:  Transl Oncol       Date:  2009-12       Impact factor: 4.243

7.  Magnetic resonance assessment of response to therapy: tumor change measurement, truth data and error sources.

Authors:  Edward F Jackson; Daniel P Barboriak; Luc M Bidaut; Charles R Meyer
Journal:  Transl Oncol       Date:  2009-12       Impact factor: 4.243

8.  Applications of the repeatability of quantitative imaging biomarkers: a review of statistical analysis of repeat data sets.

Authors:  Huiman X Barnhart; Daniel P Barboriak
Journal:  Transl Oncol       Date:  2009-12       Impact factor: 4.243

9.  Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations.

Authors:  Anwar R Padhani; Guoying Liu; Dow Mu Koh; Thomas L Chenevert; Harriet C Thoeny; Taro Takahara; Andrew Dzik-Jurasz; Brian D Ross; Marc Van Cauteren; David Collins; Dima A Hammoud; Gordon J S Rustin; Bachir Taouli; Peter L Choyke
Journal:  Neoplasia       Date:  2009-02       Impact factor: 5.715

Review 10.  From RECIST to PERCIST: Evolving Considerations for PET response criteria in solid tumors.

Authors:  Richard L Wahl; Heather Jacene; Yvette Kasamon; Martin A Lodge
Journal:  J Nucl Med       Date:  2009-05       Impact factor: 10.057

View more
  28 in total

1.  3D Slicer as an image computing platform for the Quantitative Imaging Network.

Authors:  Andriy Fedorov; Reinhard Beichel; Jayashree Kalpathy-Cramer; Julien Finet; Jean-Christophe Fillion-Robin; Sonia Pujol; Christian Bauer; Dominique Jennings; Fiona Fennessy; Milan Sonka; John Buatti; Stephen Aylward; James V Miller; Steve Pieper; Ron Kikinis
Journal:  Magn Reson Imaging       Date:  2012-07-06       Impact factor: 2.546

2.  Imaging-based observational databases for clinical problem solving: the role of informatics.

Authors:  Alex A T Bui; William Hsu; Corey Arnold; Suzie El-Saden; Denise R Aberle; Ricky K Taira
Journal:  J Am Med Inform Assoc       Date:  2013-06-17       Impact factor: 4.497

Review 3.  The promise of dynamic contrast-enhanced imaging in radiation therapy.

Authors:  Yue Cao
Journal:  Semin Radiat Oncol       Date:  2011-04       Impact factor: 5.934

Review 4.  Current and future trends in imaging informatics for oncology.

Authors:  Mia A Levy; Daniel L Rubin
Journal:  Cancer J       Date:  2011 Jul-Aug       Impact factor: 3.360

5.  Systematic analysis of bias and variability of morphologic features for lung lesions in computed tomography.

Authors:  Jocelyn Hoye; Justin Solomon; Thomas J Sauer; Marthony Robins; Ehsan Samei
Journal:  J Med Imaging (Bellingham)       Date:  2019-03-26

6.  Comparison of manual and semi-automatic measuring techniques in MSCT scans of patients with lymphoma: a multicentre study.

Authors:  A J Höink; J Weßling; R Koch; C Schülke; N Kohlhase; L Wassenaar; R M Mesters; M D'Anastasi; M Fabel; A Wulff; D Pinto dos Santos; A Kießling; A Graser; V Dicken; M Karpitschka; L Bornemann; W Heindel; B Buerke
Journal:  Eur Radiol       Date:  2014-09-06       Impact factor: 5.315

7.  Dynamic PET simulator via tomographic emission projection for kinetic modeling and parametric image studies.

Authors:  Ida Häggström; Bradley J Beattie; C Ross Schmidtlein
Journal:  Med Phys       Date:  2016-06       Impact factor: 4.071

8.  Quantitative Imaging Network: Data Sharing and Competitive AlgorithmValidation Leveraging The Cancer Imaging Archive.

Authors:  Jayashree Kalpathy-Cramer; John Blake Freymann; Justin Stephen Kirby; Paul Eugene Kinahan; Fred William Prior
Journal:  Transl Oncol       Date:  2014-02-01       Impact factor: 4.243

9.  Quantitative imaging to assess tumor response to therapy: common themes of measurement, truth data, and error sources.

Authors:  Charles R Meyer; Samuel G Armato; Charles P Fenimore; Geoffrey McLennan; Luc M Bidaut; Daniel P Barboriak; Marios A Gavrielides; Edward F Jackson; Michael F McNitt-Gray; Paul E Kinahan; Nicholas Petrick; Binsheng Zhao
Journal:  Transl Oncol       Date:  2009-12       Impact factor: 4.243

10.  Magnetic resonance assessment of response to therapy: tumor change measurement, truth data and error sources.

Authors:  Edward F Jackson; Daniel P Barboriak; Luc M Bidaut; Charles R Meyer
Journal:  Transl Oncol       Date:  2009-12       Impact factor: 4.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.